This article explores the lab AI maturity curve in biopharma R&D, from passive ELNs to active AI-powered systems that ...

Research shows that 77 percent of lab professionals now use public AI tools alongside their ELN. For many, this is not driven by policy decisions, but by necessity. Governed tools do not yet support ...

A deeper look at unmanaged AI use, also known as "shadow AI", as a response to workflow friction in laboratories.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO – Core ...